The DOI matches its Crossref record; 196 of the 196 references it cites were found in a registry or an index.
The state-of-play and future of antibody therapeutics
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Phage antibodies: filamentous phage displaying antibody variable domains
McCafferty, J., Griffiths, A. D., Winter, G., & Chiswell, D. J. (1990) · Nature · doi:10.1038/348552a0 · Cited by 2,423
Derivation of specific antibody‐producing tissue culture and tumor lines by cell fusion
Köhler, G., & Milstein, C. (1976) · European Journal of Immunology · doi:10.1002/eji.1830060713 · Cited by 1,922
Marks, J. D., Hoogenboom, H. R., Bonnert, T. P., McCafferty, J., Griffiths, A. D., & Winter, G. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90498-u · Cited by 1,603
Reshaping human antibodies for therapy
Riechmann, L., Clark, M., Waldmann, H., & Winter, G. (1988) · Nature · doi:10.1038/332323a0 · Cited by 1,562
Replacing the complementarity-determining regions in a human antibody with those from a mouse
Jones, P. T., Dear, P. H., Foote, J., Neuberger, M. S., & Winter, G. (1986) · Nature · doi:10.1038/321522a0 · Cited by 1,406
Therapeutic antibodies: successes, limitations and hopes for the future
Chames, P., Van Regenmortel, M., Weiss, E., & Baty, D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00190.x · Cited by 1,382
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
Junutula, J. R., Raab, H., Clark, S., Bhakta, S., Leipold, D. D., Weir, S., Chen, Y., Simpson, M., Tsai, S. P., Dennis, M. S., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt.1480 · Cited by 1,382
The therapeutic monoclonal antibody market
Ecker, D. M., Jones, S. D., & Levine, H. L. (2015) · mAbs · doi:10.4161/19420862.2015.989042 · Cited by 1,286
Topp, M. S., Gökbuget, N., Stein, A. S., Zugmaier, G., O'Brien, S., Bargou, R. C., Dombret, H., Fielding, A. K., Heffner, L., Larson, R. A., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71170-2 · Cited by 1,269
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
Doronina, S. O., Toki, B. E., Torgov, M. Y., Mendelsohn, B. A., Cerveny, C. G., Chace, D. F., DeBlanc, R. L., Gearing, R. P., Bovee, T. D., Siegall, C. B., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt832 · Cited by 1,206
Assembly of combinatorial antibody libraries on phage surfaces: the gene III site.
Barbas, C. F., Kang, A. S., Lerner, R. A., & Benkovic, S. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.18.7978 · Cited by 1,183
Shields, R. L., Namenuk, A. K., Hong, K., Meng, Y. G., Rae, J., Briggs, J., Xie, D., Lai, J., Stadlen, A., Li, B., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009483200 · Cited by 1,161
Stability of Protein Pharmaceuticals: An Update
Manning, M. C., Chou, D. K., Murphy, B. M., Payne, R. W., & Katayama, D. S. (2010) · Pharmaceutical Research · doi:10.1007/s11095-009-0045-6 · Cited by 1,098
Hoogenboom, H. R., Griffiths, A. D., Johnson, K. S., Chiswell, D. J., Hudson, P., & Winter, G. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.15.4133 · Cited by 1,020
Antibody Structure, Instability, and Formulation
Wang, W., Singh, S., Zeng, D. L., King, K., & Nema, S. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20727 · Cited by 941
Targeted Cancer Therapy: Conferring Specificity to Cytotoxic Drugs
Chari, R. V. J. (2008) · Accounts of Chemical Research · doi:10.1021/ar700108g · Cited by 815
‘Knobs-into-holes’ engineering of antibody CH3 domains for heavy chain heterodimerization
Ridgway, J. B. B., Presta, L. G., & Carter, P. (1996) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/9.7.617 · Cited by 810
Properties, production, and applications of camelid single-domain antibody fragments
Harmsen, M. M., & De Haard, H. J. (2007) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-007-1142-2 · Cited by 809
Generation of a Large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda
Huse, W. D., Sastry, L., Iverson, S. A., Kang, A. S., Alting-Mees, M., Burton, D. R., Benkovic, S. J., & Lerner, R. A. (1989) · Science · doi:10.1126/science.2531466 · Cited by 805
Engineered antibody Fc variants with enhanced effector function
Lazar, G. A., Dang, W., Karki, S., Vafa, O., Peng, J. S., Hyun, L., Chan, C., Chung, H. S., Eivazi, A., Yoder, S. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508123103 · Cited by 803
The promise and challenge of high-throughput sequencing of the antibody repertoire
Georgiou, G., Ippolito, G. C., Beausang, J., Busse, C. E., Wardemann, H., & Quake, S. R. (2014) · Nature Biotechnology · doi:10.1038/nbt.2782 · Cited by 652
Structure-Immunogenicity Relationships of Therapeutic Proteins
Hermeling, S., Crommelin, D. J. A., Schellekens, H., & Jiskoot, W. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000029275.41323.a6 · Cited by 617
Design of therapeutic proteins with enhanced stability
Chennamsetty, N., Voynov, V., Kayser, V., Helk, B., & Trout, B. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904191106 · Cited by 598
Self-citationSynthesis of site-specific antibody-drug conjugates using unnatural amino acids
Axup, J. Y., Bajjuri, K. M., Ritland, M., Hutchins, B. M., Kim, C. H., Kazane, S. A., Halder, R., Forsyth, J. S., Santidrian, A. F., Stafin, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211023109 · Cited by 596
Erickson, H. K., Park, P. U., Widdison, W. C., Kovtun, Y. V., Garrett, L. M., Hoffman, K., Lutz, R. J., Goldmacher, V. S., & Blättler, W. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4489 · Cited by 584
The isolation and structure of a remarkable marine animal antineoplastic constituent: dolastatin 10
Pettit, G. R., Kamano, Y., Herald, C. L., Tuinman, A. A., Boettner, F. E., Kizu, H., Schmidt, J. M., Baczynskyj, L., Tomer, K. B., & Bontems, R. J. (1987) · Journal of the American Chemical Society · doi:10.1021/ja00256a070 · Cited by 583
Unraveling the role of proteases in cancer
Koblinski, J. E., Ahram, M., & Sloane, B. F. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00224-7 · Cited by 580
Kontermann, R. E., & Brinkmann, U. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.02.008 · Cited by 578
Recovery and purification process development for monoclonal antibody production
Liu, H. F., Ma, J., Winter, C., & Bayer, R. (2010) · mAbs · doi:10.4161/mabs.2.5.12645 · Cited by 561
Industrial choices for protein production by large-scale cell culture
Chu, L., & Robinson, D. K. (2001) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00197-x · Cited by 547
Feldhaus, M. J., Siegel, R. W., Opresko, L. K., Coleman, J. R., Feldhaus, J. M. W., Yeung, Y. A., Cochran, J. R., Heinzelman, P., Colby, D., Swers, J., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt785 · Cited by 520
Doronina, S. O., Mendelsohn, B. A., Bovee, T. D., Cerveny, C. G., Alley, S. C., Meyer, D. L., Oflazoglu, E., Toki, B. E., Sanderson, R. J., Zabinski, R. F., et al. (2006) · Bioconjugate Chemistry · doi:10.1021/bc0502917 · Cited by 515
Identification of multiple sources of charge heterogeneity in a recombinant antibody
Harris, R. J., Kabakoff, B., Macchi, F. D., Shen, F. J., Kwong, M., Andya, J. D., Shire, S. J., Bjork, N., Totpal, K., & Chen, A. B. (2001) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)00548-x · Cited by 500
Schaefer, W., Regula, J. T., Bähner, M., Schanzer, J., Croasdale, R., Dürr, H., Gassner, C., Georges, G., Kettenberger, H., Imhof-Jung, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019002108 · Cited by 482
Birch, J. R., & Racher, A. J. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.12.006 · Cited by 471
Yun, Y., Cho, Y. W., & Park, K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.007 · Cited by 444
Human antibodies from transgenic animals.
Lonberg, N. (2005) · Nature Biotechnology · doi:10.1038/nbt1135 · Cited by 434
Hoogenboom, H. R., & Winter, G. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90894-p · Cited by 429
Optimization of humanized IgGs in glycoengineered Pichia pastoris
Li, H., Sethuraman, N., Stadheim, T. A., Zha, D., Prinz, B., Ballew, N., Bobrowicz, P., Choi, B.-K., Cook, W. J., Cukan, M., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1178 · Cited by 428
High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire
DeKosky, B. J., Ippolito, G. C., Deschner, R. P., Lavinder, J. J., Wine, Y., Rawlings, B. M., Varadarajan, N., Giesecke, C., Dörner, T., Andrews, S. F., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2492 · Cited by 410
Interactions of formulation excipients with proteins in solution and in the dried state
Ohtake, S., Kita, Y., & Arakawa, T. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.011 · Cited by 398
Semisynthetic combinatorial antibody libraries: a chemical solution to the diversity problem.
Barbas, C. F., Bain, J. D., Hoekstra, D. M., & Lerner, R. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4457 · Cited by 375
Hanes, J., Schaffitzel, C., Knappik, A., & Plückthun, A. (2000) · Nature Biotechnology · doi:10.1038/82407 · Cited by 373
Zimmerman, E. S., Heibeck, T. H., Gill, A., Li, X., Murray, C. J., Madlansacay, M. R., Tran, C., Uter, N. T., Yin, G., Rivers, P. J., et al. (2014) · Bioconjugate Chemistry · doi:10.1021/bc400490z · Cited by 363
Blinatumomab: A historical perspective
Nagorsen, D., Kufer, P., Baeuerle, P. A., & Bargou, R. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.07.013 · Cited by 355
Formulation and delivery issues for monoclonal antibody therapeutics
Daugherty, A. L., & Mrsny, R. J. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.03.011 · Cited by 351
The Zyggregator method for predicting protein aggregation propensities
Tartaglia, G. G., & Vendruscolo, M. (2008) · Chemical Society Reviews · doi:10.1039/b706784b · Cited by 349
β-Lactamase Inhibitors Derived from Single-Domain Antibody Fragments Elicited in the Camelidae
Conrath, K. E., Lauwereys, M., Galleni, M., Matagne, A., Frère, J.-M., Kinne, J., Wyns, L., & Muyldermans, S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2807-2812.2001 · Cited by 347
Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin
Wu, C., Ying, H., Grinnell, C., Bryant, S., Miller, R., Clabbers, A., Bose, S., McCarthy, D., Zhu, R.-R., Santora, L., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1345 · Cited by 344
Recent Developments in the Maytansinoid Antitumor Agents
Cassady, J. M., Chan, K. K., Floss, H. G., & Leistner, E. (2004) · CHEMICAL & PHARMACEUTICAL BULLETIN · doi:10.1248/cpb.52.1 · Cited by 342
Schaefer, G., Haber, L., Crocker, L. M., Shia, S., Shao, L., Dowbenko, D., Totpal, K., Wong, A., Lee, C. V., Stawicki, S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.003 · Cited by 341
Fragmentation of monoclonal antibodies
Vlasak, J., & Ionescu, R. (2011) · mAbs · doi:10.4161/mabs.3.3.15608 · Cited by 331
Mimura, Y., Church, S., Ghirlando, R., Ashton, P. R., Dong, S., Goodall, M., Lund, J., & Jefferis, R. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(00)00105-x · Cited by 329
Monoclonal TCR-redirected tumor cell killing
Liddy, N., Bossi, G., Adams, K. J., Lissina, A., Mahon, T. M., Hassan, N. J., Gavarret, J., Bianchi, F. C., Pumphrey, N. J., Ladell, K., et al. (2012) · Nature Medicine · doi:10.1038/nm.2764 · Cited by 324
Reddy, S. T., Ge, X., Miklos, A. E., Hughes, R. A., Kang, S. H., Hoi, K. H., Chrysostomou, C., Hunicke-Smith, S. P., Iverson, B. L., Tucker, P. W., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1673 · Cited by 292
Stavenhagen, J. B., Gorlatov, S., Tuaillon, N., Rankin, C. T., Li, H., Burke, S., Huang, L., Johnson, S., Bonvini, E., & Koenig, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0696 · Cited by 284
Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects
Gunasekaran, K., Pentony, M., Shen, M., Garrett, L., Forte, C., Woodward, A., Ng, S. B., Born, T., Retter, M., Manchulenko, K., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.117382 · Cited by 280
Detalle, L., Stohr, T., Palomo, C., Piedra, P. A., Gilbert, B. E., Mas, V., Millar, A., Power, U. F., Stortelers, C., Allosery, K., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01802-15 · Cited by 279
van Geel, R., Wijdeven, M. A., Heesbeen, R., Verkade, J. M. M., Wasiel, A. A., van Berkel, S. S., & van Delft, F. L. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00224 · Cited by 279
Recombination of a mixture of univalent antibody fragments of different specificity
Nisonoff, A., & Rivers, M. M. (1961) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(61)90296-x · Cited by 277
Joubert, M. K., Hokom, M., Eakin, C., Zhou, L., Deshpande, M., Baker, M. P., Goletz, T. J., Kerwin, B. A., Chirmule, N., Narhi, L. O., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.330902 · Cited by 268
In Vivo Deamidation Characterization of Monoclonal Antibody by LC/MS/MS
Huang, L., Lu, J., Wroblewski, V. J., Beals, J. M., & Riggin, R. M. (2005) · Analytical Chemistry · doi:10.1021/ac0494174 · Cited by 266
Girish, S., Gupta, M., Wang, B., Lu, D., Krop, I. E., Vogel, C. L., Burris III, H. A., LoRusso, P. M., Yi, J.-H., Saad, O., et al. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1817-3 · Cited by 262
BiTEs: bispecific antibody constructs with unique anti-tumor activity
Wolf, E., Hofmeister, R., Kufer, P., Schlereth, B., & Baeuerle, P. A. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03554-3 · Cited by 260
Moore, P. A., Zhang, W., Rainey, G. J., Burke, S., Li, H., Huang, L., Gorlatov, S., Veri, M. C., Aggarwal, S., Yang, Y., et al. (2011) · Blood · doi:10.1182/blood-2010-09-306449 · Cited by 260
Fahrner, R. L., Knudsen, H. L., Basey, C. D., Galan, W., Feuerhelm, D., Vanderlaan, M., & Blank, G. S. (2001) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2001.10648017 · Cited by 259
Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies
Wang, W., Vlasak, J., Li, Y., Pristatsky, P., Fang, Y., Pittman, T., Roman, J., Wang, Y., Prueksaritanont, T., & Ionescu, R. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2010.12.009 · Cited by 257
AGGRESCAN3D (A3D): server for prediction of aggregation properties of protein structures
Zambrano, R., Jamroz, M., Szczasiuk, A., Pujols, J., Kmiecik, S., & Ventura, S. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv359 · Cited by 253
Polson, A. G., Calemine-Fenaux, J., Chan, P., Chang, W., Christensen, E., Clark, S., de Sauvage, F. J., Eaton, D., Elkins, K., Elliott, J. M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2250 · Cited by 252
Sahin, E., Grillo, A. O., Perkins, M. D., & Roberts, C. J. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22198 · Cited by 247
Effective Immunoconjugate Therapy in Cancer Models Targeting a Serine Protease of Tumor Fibroblasts
Ostermann, E., Garin-Chesa, P., Heider, K. H., Kalat, M., Lamche, H., Puri, C., Kerjaschki, D., Rettig, W. J., & Adolf, G. R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5211 · Cited by 246
Mizushima, T., Yagi, H., Takemoto, E., Shibata‐Koyama, M., Isoda, Y., Iida, S., Masuda, K., Satoh, M., & Kato, K. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2011.01552.x · Cited by 245
The PASTA server for protein aggregation prediction
Trovato, A., Seno, F., & Tosatto, S. C. E. (2007) · Protein Engineering Design and Selection · doi:10.1093/protein/gzm042 · Cited by 243
Vandamme (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s1045 · Cited by 238
Selection methods for high-producing mammalian cell lines
Browne, S. M., & Al-Rubeai, M. (2007) · Trends in Biotechnology · doi:10.1016/j.tibtech.2007.07.002 · Cited by 237
Inhaled nano- and microparticles for drug delivery
El-Sherbiny, I. M., El-Baz, N. M., & Yacoub, M. H. (2015) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2015.2 · Cited by 236
Application of phage display to high throughput antibody generation and characterization
Schofield, D. J., Pope, A. R., Clementel, V., Buckell, J., Chapple, S. D., Clarke, K. F., Conquer, J. S., Crofts, A. M., Crowther, S. R., Dyson, M. R., et al. (2007) · Genome Biology · doi:10.1186/gb-2007-8-11-r254 · Cited by 236
Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface
Lewis, S. M., Wu, X., Pustilnik, A., Sereno, A., Huang, F., Rick, H. L., Guntas, G., Leaver-Fay, A., Smith, E. M., Ho, C., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2797 · Cited by 234
Jespers, L. S., Roberts, A., Mahler, S. M., Winter, G., & Hoogenboom, H. R. (1994) · Nature Biotechnology · doi:10.1038/nbt0994-899 · Cited by 233
Blackstone, E. A., & Joseph, P. F. (2013) · PubMed · Cited by 233
Jakobovits, A., Amado, R. G., Yang, X., Roskos, L., & Schwab, G. (2007) · Nature Biotechnology · doi:10.1038/nbt1337 · Cited by 230
Recent advances in mammalian protein production
Bandaranayake, A. D., & Almo, S. C. (2014) · FEBS Letters · doi:10.1016/j.febslet.2013.11.035 · Cited by 222
Elgersma, R. C., Coumans, R. G. E., Huijbregts, T., Menge, W. M. P. B., Joosten, J. A. F., Spijker, H. J., de Groot, F. M. H., van der Lee, M. M. C., Ubink, R., van den Dobbelsteen, D. J., et al. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500781a · Cited by 221
Production of antibodies in plants: status after twenty years
De Muynck, B., Navarre, C., & Boutry, M. (2010) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2009.00494.x · Cited by 218
Oxidation of Therapeutic Proteins and Peptides: Structural and Biological Consequences
Torosantucci, R., Schöneich, C., & Jiskoot, W. (2014) · Pharmaceutical Research · doi:10.1007/s11095-013-1199-9 · Cited by 215
Prediction of aggregation rate and aggregation‐prone segments in polypeptide sequences
Tartaglia, G. G., Cavalli, A., Pellarin, R., & Caflisch, A. (2005) · Protein Science · doi:10.1110/ps.051471205 · Cited by 214
Marketing approval of mogamulizumab: A triumph for glyco-engineering
Beck, A., & Reichert, J. M. (2012) · mAbs · doi:10.4161/mabs.20996 · Cited by 211
Rossi, E. A., Goldenberg, D. M., Cardillo, T. M., McBride, W. J., Sharkey, R. M., & Chang, C.-H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600982103 · Cited by 209
Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli
Mazor, Y., Van Blarcom, T., Mabry, R., Iverson, B. L., & Georgiou, G. (2007) · Nature Biotechnology · doi:10.1038/nbt1296 · Cited by 208
Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity.
Staerz, U. D., & Bevan, M. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.5.1453 · Cited by 208
PRISM: protein interactions by structural matching
Ogmen, U., Keskin, O., Aytuna, A. S., Nussinov, R., & Gursoy, A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki585 · Cited by 207
Assembly of monoclonal antibodies with IgG1 and IgA heavy chain domains in transgenic tobacco plants
Ma, J. K., Lehner, T., Stabila, P., Fux, C. I., & Hiatt, A. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240120 · Cited by 206
Prediction of "hot spots" of aggregation in disease-linked polypeptides
de Groot, N. S., Pallarés, I., Avilés, F. X., Vendrell, J., & Ventura, S. (2005) · BMC Structural Biology · doi:10.1186/1472-6807-5-18 · Cited by 204
Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics
Kipriyanov, S. M., Moldenhauer, G., Schuhmacher, J., Cochlovius, B., Von der Lieth, C.-W., Matys, E. R., & Little, M. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3156 · Cited by 202
Prediction of aggregation prone regions of therapeutic proteins
Chennamsetty, N., Voynov, V., Kayser, V., Helk, B., & Trout, B. L. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp911706q · Cited by 200
Self-citationAntibody affinity maturation using bacterial surface display
Daugherty, P. S., Chen, G., Olsen, M. J., Iverson, B. L., & Georgiou, G. (1998) · Protein Engineering Design and Selection · doi:10.1093/protein/11.9.825 · Cited by 199
Chang, L. (., Shepherd, D., Sun, J., Tang, X. (., & Pikal, M. J. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20363 · Cited by 199
Hong, D. S., Hui, D., Bruera, E., Janku, F., Naing, A., Falchook, G. S., Piha-Paul, S., Wheler, J. J., Fu, S., Tsimberidou, A. M., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70155-x · Cited by 199
Potential aggregation prone regions in biotherapeutics: A survey of commercial monoclonal antibodies
Wang, X., Das, T. K., Singh, S. K., & Kumar, S. (2009) · mAbs · doi:10.4161/mabs.1.3.8035 · Cited by 198
Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature.
Burrows, F. J., & Thorpe, P. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.8996 · Cited by 198
Johnson, S., Burke, S., Huang, L., Gorlatov, S., Li, H., Wang, W., Zhang, W., Tuaillon, N., Rainey, J., Barat, B., et al. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.04.001 · Cited by 198
Davis, J. H., Aperlo, C., Li, Y., Kurosawa, E., Lan, Y., Lo, K.-M., & Huston, J. S. (2010) · Protein Engineering, Design and Selection · doi:10.1093/protein/gzp094 · Cited by 194
Erickson, H. K., Lewis Phillips, G. D., Leipold, D. D., Provenzano, C. A., Mai, E., Johnson, H. A., Gunter, B., Audette, C. A., Gupta, M., Pinkas, J., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0727 · Cited by 194
Zeidler, R., Mysliwietz, J., Csánady, M., Walz, A., Ziegler, I., Schmitt, B., Wollenberg, B., & Lindhofer, H. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1237 · Cited by 189
High performance tangential flow filtration
van Reis, R., Gadam, S., Frautschy, L. N., Orlando, S., Goodrich, E. M., Saksena, S., Kuriyel, R., Simpson, C. M., Pearl, S., & Zydney, A. L. (1997) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19971005)56:1<71::aid-bit8>3.0.co;2-s · Cited by 183
A proteomics approach for the identification and cloning of monoclonal antibodies from serum
Cheung, W. C., Beausoleil, S. A., Zhang, X., Sato, S., Schieferl, S. M., Wieler, J. S., Beaudet, J. G., Ramenani, R. K., Popova, L., Comb, M. J., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2167 · Cited by 183
Ahmadi, M., Bryson, C. J., Cloake, E. A., Welch, K., Filipe, V., Romeijn, S., Hawe, A., Jiskoot, W., Baker, M. P., & Fogg, M. H. (2015) · Pharmaceutical Research · doi:10.1007/s11095-014-1541-x · Cited by 177
Aglycosylated immunoglobulin G1variants productively engage activating Fc receptors
Sazinsky, S. L., Ott, R. G., Silver, N. W., Tidor, B., Ravetch, J. V., & Wittrup, K. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809257105 · Cited by 177
The development of pyrrolobenzodiazepines as antitumour agents
Hartley, J. A. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.573477 · Cited by 175
Ravn, U., Gueneau, F., Baerlocher, L., Osteras, M., Desmurs, M., Malinge, P., Magistrelli, G., Farinelli, L., Kosco-Vilbois, M. H., & Fischer, N. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq789 · Cited by 173
Crystalline monoclonal antibodies for subcutaneous delivery
Yang, M. X., Shenoy, B., Disttler, M., Patel, R., McGrath, M., Pechenov, S., & Margolin, A. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1131899100 · Cited by 172
Glycosylation influences on the aggregation propensity of therapeutic monoclonal antibodies
Kayser, V., Chennamsetty, N., Voynov, V., Forrer, K., Helk, B., & Trout, B. L. (2011) · Biotechnology Journal · doi:10.1002/biot.201000091 · Cited by 172
Self-citationDrugs derived from phage display: From candidate identification to clinical practice
Nixon, A. E., Sexton, D. J., & Ladner, R. C. (2014) · mAbs · doi:10.4161/mabs.27240 · Cited by 167
Wei, Z., Feng, J., Lin, H.-Y., Mullapudi, S., Bishop, E., Tous, G. I., Casas-Finet, J., Hakki, F., Strouse, R., & Schenerman, M. A. (2007) · Analytical Chemistry · doi:10.1021/ac062311j · Cited by 166
BiTE: Teaching antibodies to engage T-cells for cancer therapy.
Baeuerle, P. A., Kufer, P., & Bargou, R. C. (2009) · PubMed · Cited by 165
Behrens, C. R., Ha, E. H., Chinn, L. L., Bowers, S., Probst, G., Fitch-Bruhns, M., Monteon, J., Valdiosera, A., Bermudez, A., Liao-Chan, S., et al. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00432 · Cited by 162
Jung, S. T., Reddy, S. T., Kang, T. H., Borrok, M. J., Sandlie, I., Tucker, P. W., & Georgiou, G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908590107 · Cited by 160
Asparagine Deamidation Dependence on Buffer Type, pH, and Temperature
Pace, A. L., Wong, R. L., Zhang, Y. T., Kao, Y.-H., & Wang, Y. J. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23529 · Cited by 159
Revisiting the Role of Glycosylation in the Structure of Human IgG Fc
Borrok, M. J., Jung, S. T., Kang, T. H., Monzingo, A. F., & Georgiou, G. (2012) · ACS Chemical Biology · doi:10.1021/cb300130k · Cited by 158
Inhaled proteins: Challenges and perspectives
Depreter, F., Pilcer, G., & Amighi, K. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.031 · Cited by 145
Current methods for the synthesis of homogeneous antibody–drug conjugates
Sochaj, A. M., Świderska, K. W., & Otlewski, J. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.05.001 · Cited by 142
Smits, L. J. T., Derikx, L. A. A. P., de Jong, D. J., Boshuizen, R. S., van Esch, A. A. J., Drenth, J. P. H., & Hoentjen, F. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw087 · Cited by 141
Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase
Shpilberg, O., & Jackisch, C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.371 · Cited by 138
Telikepalli, S. N., Kumru, O. S., Kalonia, C. K., Esfandiary, R., Joshi, S. B., Middaugh, C. R., & Volkin, D. B. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23839 · Cited by 137
Efficient expression of full-length antibodies in the cytoplasm of engineered bacteria
Robinson, M.-P., Ke, N., Lobstein, J., Peterson, C., Szkodny, A., Mansell, T. J., Tuckey, C., Riggs, P. D., Colussi, P. A., Noren, C. J., et al. (2015) · Nature Communications · doi:10.1038/ncomms9072 · Cited by 131
Preithner, S., Elm, S., Lippold, S., Locher, M., Wolf, A., da Silva, A. J., Baeuerle, P. A., & Prang, N. S. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.07.010 · Cited by 131
Davies, J., & Riechmann, L. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01313-x · Cited by 129
Liu, H., Gaza‐Bulseco, G., & Sun, J. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.03.053 · Cited by 127
The Immunogenicity of Antibody Aggregates in a Novel Transgenic Mouse Model
Bessa, J., Boeckle, S., Beck, H., Buckel, T., Schlicht, S., Ebeling, M., Kiialainen, A., Koulov, A. V., Boll, B., Weiser, T. W., et al. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1627-0 · Cited by 125
Arosio, P., Rima, S., & Morbidelli, M. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0885-3 · Cited by 123
Improving biophysical properties of a bispecific antibody scaffold to aid developability
von Kreudenstein, T. S., Escobar-Cabrera, E., Lario, P. I., D’Angelo, I., Brault, K., Kelly, J. F., Durocher, Y., Baardsnes, J., Woods, R. J., Xie, M. H., et al. (2013) · mAbs · doi:10.4161/mabs.25632 · Cited by 123
Evaluation of a Non-Arrhenius Model for Therapeutic Monoclonal Antibody Aggregation
Kayser, V., Chennamsetty, N., Voynov, V., Helk, B., Forrer, K., & Trout, B. L. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22493 · Cited by 120
Self-citationStreit, M., Beleznay, Z., & Braathen, L. R. (2006) · International Wound Journal · doi:10.1111/j.1742-481x.2006.00233.x · Cited by 117
Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges
Lehmann‐Horn, K., Kronsbein, H. C., & Weber, M. S. (2013) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285612474333 · Cited by 116
Deep sequencing of phage display libraries to support antibody discovery
Ravn, U., Didelot, G., Venet, S., Ng, K.-T., Gueneau, F., Rousseau, F., Calloud, S., Kosco‐Vilbois, M. H., & Fischer, N. (2013) · Methods · doi:10.1016/j.ymeth.2013.03.001 · Cited by 115
Vaklavas, C., & Forero, A. (2012) · Therapeutic Advances in Hematology · doi:10.1177/2040620712443076 · Cited by 115
Chitosan−Alginate Microcapsules for Oral Delivery of Egg Yolk Immunoglobulin (IgY)
Li, X., Jin, L., McAllister, T. A., Stanford, K., Xu, J.-Y., Lu, Y., Zhen, Y., Sun, Y., & Xu, Y. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf062900q · Cited by 113
Conjugation of Anticancer Drugs Through Endogenous Monoclonal Antibody Cysteine Residues
Lyon, R. P., Meyer, D. L., Setter, J. R., & Senter, P. D. (2011) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-416039-2.00006-9 · Cited by 111
Maiese, W. M., Lechevalier, M. P., Lechevalier, H. A., KORSHALLA, J. D., KUCK, N. A., Fantini, A. A., Wildey, M. J., Thomas, J., & Greenstein, M. D. (1989) · The Journal of Antibiotics · doi:10.7164/antibiotics.42.558 · Cited by 110
Rehder, D. S., Chelius, D., McAuley, A., Dillon, T. M., Xiao, G., Crouse-Zeineddini, J., Vardanyan, L., Perico, N., Mukku, V., Brems, D. N., et al. (2008) · Biochemistry · doi:10.1021/bi7018223 · Cited by 110
Bendell, J. C., Saleh, M. N., Rose, A. A. N., Siegel, P. M., Hart, L. L., Sirpal, S., Jones, S. F., Green, J., Crowley, E. M., Simantov, R., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.5683 · Cited by 108
Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study
Zhang, N., Liu, L., Dumitru, C. D., Houston-Cummings, N. R., Cukan, M. C., Jiang, Y., Li, Y., Li, F., Mitchell, T., Mallem, M. R., et al. (2011) · mAbs · doi:10.4161/mabs.3.3.15532 · Cited by 97
Subramaniam, J., Whiteside, G., McKeage, K., & Croxtall, J. C. (2012) · Drugs · doi:10.2165/11631090-000000000-00000 · Cited by 96
Bot, A. I., Tarara, T. E., Smith, D. J., Bot, S., Woods, C. M., & Weers, J. G. (2000) · Pharmaceutical Research · doi:10.1023/a:1007544804864 · Cited by 95
Chartrain, M. M., & Chu, L. (2008) · Current Pharmaceutical Biotechnology · doi:10.2174/138920108786786367 · Cited by 94
Kim, N., Remmele, R. L., Liu, D., Razinkov, V. I., Fernández, E., & Roberts, C. J. (2012) · Biophysical Chemistry · doi:10.1016/j.bpc.2012.12.004 · Cited by 89
Koussoroplis, S. J., Paulissen, G., Tyteca, D., Goldansaz, H., Todoroff, J., Barilly, C., Uyttenhove, C., Snick, J. V., Cataldo, D. D., & Rita Vanbever, A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.021 · Cited by 85
Yan, Y., Wei, H., Fu, Y., Jusuf, S., Zeng, M., Ludwig, R. T., Krystek, S. R., Chen, G., Tao, L., & Das, T. K. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b02800 · Cited by 84
A review of blinatumomab, a novel immunotherapy
Newman, M. J., & Benani, D. J. (2015) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155215618770 · Cited by 84
Saggy, I., Wine, Y., Shefet-Carasso, L., Nahary, L., Georgiou, G., & Benhar, I. (2012) · Protein Engineering Design and Selection · doi:10.1093/protein/gzs060 · Cited by 82
Competing aggregation pathways for monoclonal antibodies
Wu, H., Kroe‐Barrett, R., Singh, S., Robinson, A. S., & Roberts, C. J. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.01.051 · Cited by 82
Liu, S. D., Chalouni, C. M., Young, J. C., Junttila, T. T., Sliwkowski, M. X., & Lowe, J. B. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0125 · Cited by 80
Razinkov, V. I., Treuheit, M. J., & Becker, G. W. (2015) · SLAS DISCOVERY · doi:10.1177/1087057114565593 · Cited by 78
Ott, M., Marmé, F., Moldenhauer, G., Lindhofer, H., Hennig, M., Spannagl, R., Essing, M. M., Linke, R., & Seimetz, D. (2011) · International Journal of Cancer · doi:10.1002/ijc.26258 · Cited by 77
Jung, S. T., Kelton, W., Kang, T. H., Ng, D. T. W., Andersen, J. T., Sandlie, I., Sarkar, C. A., & Georgiou, G. (2012) · ACS Chemical Biology · doi:10.1021/cb300455f · Cited by 75
Nuttall, S. D., Krishnan, U. V., Doughty, L., Pearson, K., Ryan, M. T., Hoogenraad, N. J., Hattarki, M. K., Carmichael, J. A., Irving, R. A., & Hudson, P. J. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03737.x · Cited by 74
Palumbo, A., Hauler, F., Dziunycz, P., Schwager, K., Soltermann, A., Pretto, F., Alonso, C., Hofbauer, G. F. L., Boyle, R. W., & Neri, D. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.78 · Cited by 72
Buffer capacity of biologics—from buffer salts to buffering by antibodies
Karow, A. R., Bahrenburg, S., & Garidel, P. (2013) · Biotechnology Progress · doi:10.1002/btpr.1682 · Cited by 71
Encapsulation of Chicken Egg Yolk Immunoglobulin G (IgY) by Liposomes
Shimizu, M., Miwa, Y., Hashimoto, K., & Goto, A. (1993) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.57.1445 · Cited by 68
Manzke, O., Tesch, H., Diehl, V., & Bohlen, H. (1997) · Journal of Immunological Methods · doi:10.1016/s0022-1759(97)00129-4 · Cited by 67
Drake, P. M., & Rabuka, D. (2015) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2015.08.005 · Cited by 66
Antibody expression kinetics in glycoengineered Pichia pastoris
Potgieter, T. I., Kersey, S. D., Mallem, M. R., Nylen, A., & d′Anjou, M. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22756 · Cited by 64
Lebreton, B., Brown, A., & van Reis, R. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21842 · Cited by 62
Cerdà‐Costa, N., Esteras‐Chopo, A., Avilés, F. X., Serrano, L. G., & Villegas, S. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.12.007 · Cited by 62
Niwa, R., & Satoh, M. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24316 · Cited by 58
Sreedhara, A., Lau, K. S. F., Li, C., Hosken, B. D., Macchi, F. D., Zhan, D., Shen, A. Y., Steinmann, D., Schöneich, C., & Lentz, Y. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300418r · Cited by 57
New perspective for phage display as an efficient and versatile technology of functional proteomics
Li, W., & Caberoy, N. B. (2009) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-2277-0 · Cited by 56
Controlled-release and local delivery of therapeutic antibodies
Grainger, D. W. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.7.1029 · Cited by 53
Zhang, Y. T., Hu, J. J., Pace, A. L., Wong, R. L., Wang, Y. J., & Kao, Y. (2014) · Journal of Chromatography B · doi:10.1016/j.jchromb.2014.06.018 · Cited by 52
Rossi, E. A., Goldenberg, D. M., & Chang, C. (2011) · Bioconjugate Chemistry · doi:10.1021/bc2004999 · Cited by 49
Controlled release of therapeutic antibody formats
Schweizer, D., Serno, T., & Göpferich, A. M. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.08.001 · Cited by 49
Human IgG1 Hinge Fragmentation as the Result of H2O2-mediated Radical Cleavage
Yan, B., Yates, Z., Balland, A., & Kleemann, G. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064147 · Cited by 49
Production of Monoclonal Antibodies in Plants for Cancer Immunotherapy
Moussavou, G., Ko, K., Lee, J. H., & Choo, Y. (2015) · BioMed Research International · doi:10.1155/2015/306164 · Cited by 48
Antibody‐Drug Conjugates: A Clinical Pharmacy Perspective on an Emerging Cancer Therapy
Jerjian, T., Glode, A. E., THOMPSON, L. A., & O’Bryant, C. L. (2016) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1687 · Cited by 47
Timm, V., Gruber, P., Wasiliu, M., Lindhofer, H., & Chelius, D. (2010) · Journal of Chromatography B · doi:10.1016/j.jchromb.2010.01.036 · Cited by 45
Novel Anti-TM4SF1 Antibody–Drug Conjugates with Activity against Tumor Cells and Tumor Vasculature
Visintin, A., Knowlton, K. M., Tyminski, E., Lin, C., Zheng, X., Marquette, K., Jain, S., Tchistiakova, L., Li, D., O’Donnell, C. J., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0188 · Cited by 45
Rational Design of Biobetters with Enhanced Stability
Courtois, F., Schneider, C. P., Agrawal, N. J., & Trout, B. L. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24520 · Cited by 43
Glutamine deamidation of a recombinant monoclonal antibody
Liu, H., Gaza‐Bulseco, G., & Chumsae, C. M. (2008) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.3831 · Cited by 43
Protein–Polyanion Interactions for the Controlled Release of Monoclonal Antibodies
Schweizer, D., Schoenhammer, K., Jahn, M., & Göpferich, A. M. (2012) · Biomacromolecules · doi:10.1021/bm301352x · Cited by 42
A variant human IgG1-Fc mediates improved ADCC
Stewart, R. A., Thom, G., Levens, M., Güler-Gane, G., Holgate, R., Rudd, P. M., Webster, C. I., Jermutus, L., & Lund, J. (2011) · Protein Engineering Design and Selection · doi:10.1093/protein/gzr015 · Cited by 42
Vázquez, A. M., Hernández, A. M., Macías, A., Montero, E., Gomez, D. E., Alonso, D. F., Gabri, M. R., & Gómez, R. E. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00150 · Cited by 42
Partial Unfolding of a Monoclonal Antibody: Role of a Single Domain in Driving Protein Aggregation
Mehta, S. B., Bee, J. S., Randolph, T. W., & Carpenter, J. F. (2014) · Biochemistry · doi:10.1021/bi5002163 · Cited by 38
Protocols for Lysine Conjugation
Brun, M., & Gauzy‐Lazo, L. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-541-5_10 · Cited by 36
RECRUIT-TandAbs ® : Harnessing the Immune System to Kill Cancer Cells
McAleese, F., & Eser, M. (2012) · Future Oncology · doi:10.2217/fon.12.54 · Cited by 36
The Application of Next Generation Sequencing to the Understanding of Antibody Repertoires
Mathonet, P., & Ullman, C. G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00265 · Cited by 36
Genentech's glyco-engineered antibody to succeed Rituxan
Ratner, M. (2014) · Nature Biotechnology · doi:10.1038/nbt0114-6b · Cited by 34
Teicher, B. A. (2014) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000108 · Cited by 32
Scott, C. T. (2007) · Nature Biotechnology · doi:10.1038/nbt1007-1075 · Cited by 26
Garrone, P., Djossou, O., Fossiez, F., Reyes, J., Aït‐Yahia, S., Maat, C., Ho, S., Hauser, T., Dayer, J., Greffe, J., et al. (1996) · Molecular Immunology · doi:10.1016/0161-5890(96)00017-x · Cited by 26
Isomerization of Asp–Asp Motif in Model Peptides and a Monoclonal Antibody Fab Fragment
Yi, L., Adeniji, N., Gikanga, B., Zhang, J., Wang, Y. J., Chih, H., & Sharma, V. K. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23423 · Cited by 24
Derer, S., Kellner, C., Berger, S., Valerius, T., & Peipp, M. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-974-7_30 · Cited by 20
Wilson, C. J. (2014) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1310 · Cited by 17
Protein Dynamics Governed by Interfaces of High Polarity and Low Packing Density
Angarica, V. E., & Sancho, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048212 · Cited by 14
Mylotarg: Revisiting Its Clinical Potential Post-Withdrawal
Zaro, J. L. (2015) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-13081-1_10 · Cited by 8
Cited by
Progress in biopharmaceutical development
Kesik‐Brodacka, M. (2018) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1617 · Cited by 353
Protein Design: From the Aspect of Water Solubility and Stability
Qing, R., Hao, S., Smorodina, E., Jin, D., Zalevsky, A., & Zhang, S. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00757 · Cited by 312
Cong, M., Tan, S., Li, S., Gao, L., Huang, L., Zhang, H.-G., & Qiao, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114108 · Cited by 302
Belov, A. M., Zang, L., Sebastiano, R., Santos, M. R., Bush, D. R., Karger, B. L., & Ivanov, A. R. (2018) · ELECTROPHORESIS · doi:10.1002/elps.201800067 · Cited by 88
McAvan, B. S., Bowsher, L. A., Powell, T., O’Hara, J. F., Spitali, M., Goodacre, R., & Doig, A. J. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c00627 · Cited by 61
Metadata
- Authors
- Elgundi, Z., Reslan, M., Cruz, E., Sifniotis, V., & Kayser, V.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 122
- Pages
- 2-19
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2558801358
- Cited by
- 322
- References
- 196
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.